Descriptor English: | Apolipoprotein L1 | ||||||
Descriptor Spanish: |
Apolipoproteína L1
| ||||||
Descriptor Portuguese: | Apolipoproteína L1 | ||||||
Descriptor French: | Apolipoprotéine L1 | ||||||
Entry term(s): |
ApoL Protein ApoL1 Protein Apolipoprotein L |
||||||
Tree number(s): |
D10.532.091.750.500 D12.776.070.400.750.500 D12.776.521.120.750.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000075944 | ||||||
Scope note: | An ApoL protein highly expressed by the liver. It has anti-trypanosomal activity through its ability to permeabilize TRYPANOSOMA membranes. Mutations in the APOL1 gene are associated with type 4 FOCAL SEGMENTAL GLOMERULOSCLEROSIS . |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Previous Indexing: |
Apolipoproteins (1997-2017) Lipoproteins, HDL (1997-2017) |
||||||
Public MeSH Note: | 2018 |
||||||
History Note: | 2018 |
||||||
DeCS ID: | 57041 | ||||||
Unique ID: | D000075944 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2018/01/01 | ||||||
Date of Entry: | 2017/07/11 | ||||||
Revision Date: | 2017/06/30 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Apolipoprotein L1
- Preferred
Concept UI |
M000631728 |
Scope note | An ApoL protein highly expressed by the liver. It has anti-trypanosomal activity through its ability to permeabilize TRYPANOSOMA membranes. Mutations in the APOL1 gene are associated with type 4 FOCAL SEGMENTAL GLOMERULOSCLEROSIS . |
Preferred term | Apolipoprotein L1 |
Entry term(s) |
ApoL Protein ApoL1 Protein Apolipoprotein L |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey